$STX

MOSLEY WILLIAM D sold $1.6M of STX

MOSLEY WILLIAM D (CEO) sold 1,768 shares of Seagate Technology Holdings plc (STX) at $880.19 ($1.56M total) on 2026-06-12.

Original reporting
SEC EDGAR · MOSLEY WILLIAM D
Published Jun 15, 2026, 9:44 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 15, 2026, 9:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$STX
Neutral
high confidence
Mentioned
$STX
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$STXNeutralLow
01

Why it matters

The newest concrete fact is the CEO’s open-market sale details (shares, price, total value, post-transaction holdings). This can marginally influence sentiment but does not, by itself, change Seagate’s operating outlook.

02

Market read

Traders may note insider selling as a minor sentiment input, but the filing lacks any fundamental catalyst (earnings, guidance, contract, or regulatory action).

03

What to watch

The article provides only one sale lot size and price; it doesn’t show total insider exposure changes over time or whether other insiders/10b5-1 plans offset this activity.

Relevance 6/10Novelty 6/10Timing: filed 2026-06-15; sale dated 2026-06-12

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Seagate Technology Holdings plc (STX).

Company-level read

Ticker impact

$STXNeutralHigh confidence
Context

Seagate CEO William D. Mosley filed an SEC Form 4 selling 1,768 shares of STX at $880.1888 on 2026-06-12.

Expected impact

Likely limited near-term impact; any effect should be small and fade unless followed by additional disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with no 10b5-1 plan and no accompanying fundamental catalyst or guidance change in the text.

Market effects

Minimal; insider selling in a single large-cap storage name rarely changes sector expectations without additional operational/regulatory news.

None indicated; US-listed filing only.

None indicated; no cross-border deal or macro linkage described.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs; absence of a stated 10b5-1 plan doesn’t necessarily imply bearish fundamentals.

Key entities

  • Seagate Technology Holdings plc

    Subject of the SEC Form 4 insider transaction disclosure.

  • MOSLEY WILLIAM D

    CEO/officer/director who sold STX shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVDAHighAI 9/10

Markets News, Aug. 27, 2026: Nvidia Stock Powers Higher After Earnings, Driving Tech Gains; Nasdaq Closes Sharply Higher

Nvidia (NVDA) reported strong Q2 earnings and raised Q3 revenue guidance to $108B, driving its stock up 9% and boosting tech sector gains. Nasdaq, S&P 500, and Dow closed higher. Other notable movers include Okta (OKTA) +29%, Salesforce (CRM) +23%, and CrowdStrike (CRWD) +20%. Corporate profits surged $400B in Q2, partly due to $71B in tariff refunds.

$STXMed

Moody’s upgrades Seagate Data rating on AI demand strength

Moody's upgraded Seagate Data's corporate family rating to Ba1 from Ba2, citing AI-driven demand for high-capacity HDDs. The agency expects revenues to grow over 30% annually, reaching $20B, and debt to EBITDA to fall below 0.5x. Seagate faces risks from revenue concentration and pricing pressures. The company had $1.7B in cash and access to a $1.3B credit facility as of July 2026.

$MRNAHighAI 8/10

3 Stocks Soared, 3 Stocks Slumped

Moderna (MRNA) surged 176.97% to $174.38 after reporting positive trial results for a cancer therapy with Merck (MRK). Estee Lauder (EL) rose 16% to $98.01 with revenue up 6.5% Y/Y. MicroStrategy (MSTR) gained 12.68% as Bitcoin prices rose. Nebius (NBIS) fell 10% after a $4.5B convertible note offering. Seagate (STX) dropped 8% to $832.56.

$STXMed

REG - Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US

Shield Therapeutics (STX) will take full control of ACCRUFeR® in the US from Viatris by September 30, 2026. The deal is expected to boost Shield's profitability and growth, with no upfront payments to Viatris. Shield will pay royalties on US net sales, ranging from high single digits to mid-teens over five years, and retain all gross profits from US sales. The transaction is anticipated to enhance Shield's financial profile and support its path to sustained profitability.